| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0052 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |